Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow CME Information
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Detterbeck, F. C.
Right arrow Articles by Socinski, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Detterbeck, F. C.
Right arrow Articles by Socinski, M. A.
(Chest. 2004;126:1656-1666.)
© 2004 American College of Chest Physicians

Seeking a Home for a PET, Part 3*

Emerging Applications of Positron Emission Tomography Imaging in the Management of Patients With Lung Cancer

Frank C. Detterbeck, MD, FCCP; Johan F. Vansteenkiste, MD, PhD; David E. Morris, MD; Christophe A. Dooms, MD; Amir H. Khandani, MD, PhD and Mark A. Socinski, MD, FCCP

* From the Multidisciplinary Thoracic Oncology Program (Drs. Detterbeck, Morris, Khandani, and Socinski), University of North Carolina, Chapel Hill, NC; and Respiratory Oncology Unit (Drs. Vansteenkiste and Dooms), Department of Pulmonology, University Hospital Gasthuisberg, Catholic University, Leuven, Belgium.

Correspondence to: Frank C. Detterbeck, MD, FCCP, Division of Cardiothoracic Surgery, Medical School Wing C - Room 354, CB #7065, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7065; e-mail: fdetter{at}med.unc.edu

Positron emission tomography (PET) imaging is an important tool to refine the diagnosis and staging approach in patients with a possible lung cancer. In addition, other applications of PET imaging are being explored. Data consistently show that the intensity of uptake on a PET scan correlates with the biological aggressiveness of a tumor. PET imaging for restaging after induction therapy does not appear to be accurate enough to guide management. The results of PET imaging late after completion of treatment are highly predictive of future survival, and changes in PET images after only one cycle of chemotherapy are predictive of how a patient will respond to that planned treatment. PET imaging may allow radiotherapy treatment fields to be planned with greater accuracy, although data on how this affects patient outcomes are not yet available. Further technologic improvements in PET scanners are likely to bring further benefits to the management of patients with lung cancer in the future.

Key Words: lung cancer • positron emission tomography




This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
D. J. Raz, A. Y. Odisho, B. L. Franc, and D. M. Jablons
Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma.
J. Thorac. Cardiovasc. Surg., November 1, 2006; 132(5): 1189 - 1195.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. Bunyaviroch and R. E. Coleman
PET Evaluation of Lung Cancer
J. Nucl. Med., March 1, 2006; 47(3): 451 - 469.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Chest Physicians.